# Denis Caillot

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/denis-caillot/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,119 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 78 |
| i10-index | 227 |
| Last Known Institution | Institut de Cancérologie de Bourgogne |
| OpenAlex ID | https://openalex.org/A5075950291 |
| ORCID iD | https://orcid.org/0009-0009-6985-5609 |
| Works | 476 |

## Researcher papers

- [Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma](https://scholariq.org/papers/lenalidomide-bortezomib-and-dexamethasone-with-transplantation-for-myeloma/)
- [Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study](https://scholariq.org/papers/bortezomib-thalidomide-and-dexamethasone-with-or-without-daratumumab-before-and/)
- [Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies](https://scholariq.org/papers/liposomal-amphotericin-b-in-combination-with-caspofungin-for-invasive/)
- [Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial](https://scholariq.org/papers/maintenance-with-daratumumab-or-observation-following-treatment-with-bortezomib/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)

## Researcher university

- [Institut de Cancérologie de Bourgogne](https://scholariq.org/institutions/institut-de-cancerologie-de-bourgogne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.